Anti-diabetics Market Forecast
05 Nov 2010 • by Natalie Aster
London – “Datamonitor expects the anti-diabetics market to grow to $34.8 billion in 2019 for the seven major markets. Januvia will become the leading franchise from 2012 after patent expiry of Actos, with franchise sales reaching nearly $6 billion by 2019. Pipeline candidates will make up 30% of sales in 2019, with once-weekly GLP-1 agonists and new long-acting insulin analogs meeting success.”
The report “Anti-diabetics Market Forecast” by Datamonitor examines the future performance of leading anti-diabetic brands and the growth of generics and insulin biosimilars.
Report Details:
Anti-diabetics Market Forecast
Publication Date: September 2010
Price: $15,400
Format: PDF & DataPack
Use the report to:
- Quantify the future size of the anti-diabetics market from 2010-2019 and identify opportunities for new products;
- Understand the barriers to uptake for novel anti-diabetic agents.
More information can be found in the report “Anti-diabetics Market Forecast” by Datamonitor.
To order the report or ask for sample pages contact [email protected]
Contacts
MarketPublishers, Ltd.
Mrs. Alla Martin
Tel: +44 208 144 6009
Fax: +44 207 900 3970
Analytics & News
